BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7583328)

  • 1. Cholecystokinin-induced release of dopamine in the nucleus accumbens of the spontaneously hypertensive rat.
    Kirouac GJ; Ganguly PK
    Brain Res; 1995 Aug; 689(2):245-53. PubMed ID: 7583328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: I. Levels of dopamine and metabolites.
    Yu ZJ; Lim DK; Hoskins B; Rockhold RW; Ho IK
    Neurochem Res; 1990 Jun; 15(6):613-9. PubMed ID: 2215853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of cholecystokinin receptors in the nucleus accumbens of the young prehypertensive spontaneously hypertensive rat.
    Kirouac GJ; Ganguly PK
    Neurosci Lett; 1995 May; 191(3):197-9. PubMed ID: 7644145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nigrostriatal dopamine system: role in the development of hypertension in spontaneously hypertensive rats.
    Linthorst AC; van Giersbergen PL; Gras M; Versteeg DH; de Jong W
    Brain Res; 1994 Mar; 639(2):261-8. PubMed ID: 8205480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo basal and amphetamine-induced striatal dopamine and metabolite levels are similar in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male rats.
    Ferguson SA; Gough BJ; Cada AM
    Physiol Behav; 2003 Oct; 80(1):109-14. PubMed ID: 14568315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nigrostriatal dopamine system and the development of hypertension in the spontaneously hypertensive rat.
    de Jong W; Linthorst AC; Versteeg HG
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1193-6. PubMed ID: 8572872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment.
    Heidbreder C; Gewiss M; De Potter W; De Witte P
    Arch Int Physiol Biochim Biophys; 1992; 100(3):267-73. PubMed ID: 1382678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats.
    Linthorst AC; De Lang H; De Jong W; Versteeg DH
    Eur J Pharmacol; 1991 Aug; 201(2-3):125-33. PubMed ID: 1686754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats.
    Van den Buuse M; Jones CR; Wagner J
    Brain Res Bull; 1992 Feb; 28(2):289-97. PubMed ID: 1375862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Ladurelle N; Keller G; Roques BP; Daugé V
    Brain Res; 1993 Nov; 628(1-2):254-62. PubMed ID: 8313154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
    Brain Res; 1995 Apr; 676(2):343-51. PubMed ID: 7614004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder.
    de Villiers AS; Russell VA; Sagvolden T; Searson A; Jaffer A; Taljaard JJ
    Neurochem Res; 1995 Apr; 20(4):427-33. PubMed ID: 7651580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro glutamate-stimulated release of dopamine from nucleus accumbens core and shell of spontaneously hypertensive rats.
    Russell VA
    Metab Brain Dis; 2003 Jun; 18(2):161-8. PubMed ID: 12822835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
    Marshall FH; Barnes S; Pinnock RD; Hughes J
    Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular catechol and indole turnover in the nucleus of the solitary tract of spontaneously hypertensive and Wistar-Kyoto normotensive rats in response to drug-induced changes in arterial blood pressure.
    Dev BR; Philip L
    Brain Res Bull; 1996; 40(2):111-6. PubMed ID: 8724428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of dopamine and 3,4-dihydroxyphenylacetic acid in the adenohypophysis of normo- and hypertensive rats.
    Sim MK; Hsu TP
    Clin Exp Hypertens A; 1990; 12(3):343-53. PubMed ID: 2357838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
    Rakovska A; Baranyi M; Windisch K; Petkova-Kirova P; Gagov H; Kalfin R
    Brain Res Bull; 2017 Sep; 134():246-252. PubMed ID: 28802898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.
    Abekawa T; Ohmori T; Koyama T
    Brain Res; 1994 Apr; 643(1-2):276-81. PubMed ID: 7518327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge.
    Birgner C; Kindlundh-Högberg AM; Nyberg F; Bergström L
    Neurosci Lett; 2007 Jan; 412(2):168-72. PubMed ID: 17123707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol.
    Quintanilla ME; Bustamante D; Tampier L; Israel Y; Herrera-Marschitz M
    Eur J Pharmacol; 2007 Nov; 573(1-3):84-92. PubMed ID: 17651729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.